B-Lymphocyte Depletion Using The Anti-CD20 Antibody Rituximab In Chronic Fatigue Syndrome
10/21/2011
Chronic fatigue syndrome (CFS) may be alleviated by the anti-cancer drug Rituximab, suggesting that the source of the disease could lie in the immune system, according to a new study published in the online journal PLoS ONE...
Age Plays A Big Role In Prostate Cancer Deaths
10/21/2011
Contrary to common belief, men age 75 and older are diagnosed with late-stage and more aggressive prostate cancer and thus die from the disease more often than younger men, according to a University of Rochester analysis published online this week by the journal, Cancer. The study is particularly relevant in light of the recent controversy about prostate cancer screening...
Finding innovative, minimally invasive ways to treat liver cancer - and being able to tailor that treatment individually to patients - are hallmarks of interventional radiologists. Advances in yttrium-90 (Y-90) radioembolization for liver cancer, a leading cause of cancer deaths worldwide, are reported in studies in the October Journal of Vascular and Interventional Radiology...
Turning Up The Heat To Kill Cancer Cells: The 'Lance Armstrong Effect'
10/21/2011
The "Lance Armstrong effect" could become a powerful new weapon to fight cancer cells that develop resistance to chemotherapy, radiation and other treatments, scientists say in a report in the ACS journal Molecular Pharmaceutics. Robert Getzenberg and Donald Coffey explain that many advances have occurred in the 40 years since President Nixon declared a "War on Cancer" on December 23, 1971...
During Brain Surgery, New Tool Helps Surgeons Remove More Cancer Tissue
10/21/2011
Scientists are reporting development and successful initial testing of a new tool that tells whether brain tissue is normal or cancerous while an operation is underway, so that surgeons can remove more of the tumor without removing healthy tissue, improving patients' survival. The report appears in ACS' journal Analytical Chemistry...
Protein In Breast Cancer Cell Nucleus Potential Target For New Medications
10/20/2011
Estrogen-related receptor alpha (ERRα), a protein in the nucleus of breast cancer cells, plays a key part in the growth of aggressive tumors - new medications that undermine the activity of the protein might help treat some types of breast cancers known as estrogen receptor negative cancers, researchers from the Duke Cancer Institute reported in the journal Cancer Cell...
Radiotherapy Nearly Halves Breast Cancer Recurrence After Breast Conserving Surgery
10/20/2011
An article published Online First and in an upcoming Lancet reveals that radiotherapy reduces breast cancer recurrence by 50% during the following 10-years after breast conserving surgery and reduces the risk of breast cancer mortality by one sixth over the next 15 years after surgery...
Regulating Skin Cancer Stem Cells: New Role For Vascular Endothelial Growth Factor
10/20/2011
Skin squamous cell carcinomas are amongst the most frequent cancers in humans. Recent studies suggest that skin squamous cell carcinoma, like many other human cancers, contain particular cancer cells, known as cancer stem cells, that present increased self-renewal potential that sustain tumor growth. Little is known about the mechanisms that regulate cancer stem cell functions...
The Efficacy Of Non-Hodgkin's Lymphoma Vaccine Demonstrated On Dogs
10/20/2011
An experimental vaccine developed by researchers at the University of Pennsylvania's schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for dogs with spontaneous non-Hodgkin's lymphoma...
Regulating Skin Cancer Stem Cells: New Role For Vascular Endothelial Growth Factor
10/20/2011
Skin squamous cell carcinomas are amongst the most frequent cancers in humans. Recent studies suggest that skin squamous cell carcinoma, like many other human cancers, contain particular cancer cells, known as cancer stem cells, that present increased self-renewal potential that sustain tumor growth. Little is known about the mechanisms that regulate cancer stem cell functions...